An Overview of Thrombin Inhibitors in the Perspective of Structure-activity Relationships

被引：3
|
作者：
Wang, Jiangming [1 ]
Sun, Xiaojing [1 ]
Li, Na [1 ]
Sheng, Ruilong [2 ]
Guo, Ruihua [1 ,3 ,4 ]
机构：
[1] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China
[2] Univ Madeira, CQM Cent Quim Madeira, Campus Penteada, P-9000390 Funchal, Portugal
[3] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China
[4] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stora, Shanghai 201306, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2023年 / 30卷 / 25期
基金：
中国国家自然科学基金;
关键词：
Antithrombotic; thrombin inhibitor; structure-activity relationship; pharmacokinetics; PROTEASE-ACTIVATED RECEPTORS; DESIGNING ALLOSTERIC REGULATORS; OPTIMIZING PLATELET INHIBITION; ORALLY BIOAVAILABLE SERIES; FACTOR XA INHIBITORS; BIOLOGICAL EVALUATION; ANTITHROMBOTIC COMPOUNDS; IN-VITRO; PART; SCUTELLAREIN DERIVATIVES;
D O I：
10.2174/0929867329666220906105200
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thrombosis is one of the most important pathogenic factors related to cardiovascular diseases. Presently, thrombin inhibitors have gradually gained prominence in clinical practice due to their unique potential, such as dabigatran. Nevertheless, the risk of bleeding is not completely eliminated, and the threats of gastrointestinal bleeding are even increased in some cases. Therefore, developing new oral thrombin inhibitors with low side effects is urgent. In this paper, we summarized recent advances in the newly synthesized and isolated thrombin inhibitors from 2000 to 2019 and their structure-activity relationships (SARs) along with structure-dependent pharmacokinetic parameters, guiding the next generation of oral thrombin inhibitors.
引用
收藏
页码：2864 / 2930
页数：67
相关论文
共 50 条
  • [31] Synthesis and structure-activity relationships of teixobactin
    Karas, John A.
    Chen, Fan
    Schneider-Futschik, Elena K.
    Kang, Zhisen
    Hussein, Maytham
    Swarbrick, James
    Hoyer, Daniel
    Giltrap, Andrew M.
    Payne, Richard J.
    Li, Jian
    Velkov, Tony
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1459 (01) : 86 - 105
  • [32] Structure-Activity Relationships and Quantitative Structure-Activity Relationships for Breast Cancer Resistance Protein (ABCG2)
    Gandhi, Yash A.
    Morris, Marilyn E.
    AAPS JOURNAL, 2009, 11 (03): : 541 - 552
  • [33] Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors
    Nishiwaki, Keiji
    Ohigashi, Kanae
    Deguchi, Takahiro
    Murata, Kazuya
    Nakamura, Shinya
    Matsuda, Hideaki
    Nakanishi, Isao
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (07) : 741 - 747
  • [34] Structure-activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions
    Numazawa, M
    Handa, W
    Hasegawa, C
    Takahashi, M
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 97 (04) : 353 - 359
  • [35] Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors
    Fatmawati, Sri
    Shimizu, Kuniyoshi
    Kondo, Ryuichiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7295 - 7297
  • [36] Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
    Sutherland, Hamish S. S.
    Lu, Guo-Liang
    Tong, Amy S. T. G.
    Conole, Daniel M.
    Franzblau, Scott G. U.
    Upton, Anna B.
    Lotlikar, Manisha U. D.
    Cooper, Christopher B. J.
    Palmer, Brian D. A.
    Choi, Peter J.
    Denny, William A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [37] Structure-Activity Relationships of Natural and Synthetic Indole-Derived Scaffolds as α-Glucosidase Inhibitors: A Mini-Review
    Wang, Jiangming
    Lu, Silei
    Sheng, Ruilong
    Fan, Junting
    Wu, Wenhui
    Guo, Ruihua
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 1791 - 1818
  • [38] Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships
    Xu, Man
    Peng, Yongzhi
    Zhu, Li
    Wang, Shulin
    Ji, Jiayou
    Rakesh, K. P.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 180 : 656 - 672
  • [39] Revisiting Structure-activity Relationships: Unleashing the potential of selective Janus kinase 1 inhibitors
    Shan, Mengyi
    Zhao, Xuan
    Sun, Peng
    Qu, Xinhao
    Cheng, Gang
    Qin, Lu-Ping
    BIOORGANIC CHEMISTRY, 2024, 149
  • [40] Comprehensive review on neprilysin (NEP) inhibitors: design, structure-activity relationships, and clinical applications
    Zhang, Xinyue
    Hu, Chun
    Tian, Erkang
    Shen, Yanxin
    Liu, Wei
    Li, Juan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345